Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FAUQ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,034
Award facts
- Contract value 100% obligated
- $72,034.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $72,034 firm fixed-price delivery order from the Defense Logistics Agency (DLA) for XOLAIR 150 mg/ml syringes. This competitively awarded contract, with no set-aside designation, is scheduled for completion by May 15, 2025. The delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026.
XOLAIR (omalizumab) is a specialty biologic medication used in the treatment of allergic asthma and chronic idiopathic urticaria, making this procurement part of the Defense Health Agency's broader effort to maintain critical pharmaceutical supplies for military personnel and beneficiaries. AmerisourceBergen's substantial IDC with DLA positions the company as a key vendor within the Pharmaceutical Prime Vendor Global Program, enabling the company to supply a comprehensive range of branded and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare systems worldwide. This delivery order reflects the company's ongoing role as a critical distributor of specialized medications within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FAUQ8?
SPE2DB25FAUQ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FAUQ8 worth?
The government has obligated $72,034 on SPE2DB25FAUQ8.
Is contract SPE2DB25FAUQ8 an order under another contract?
Yes. SPE2DB25FAUQ8 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAUQ8 competed?
The extent of competition for SPE2DB25FAUQ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award